You are here

obesity

Eli Lilly bets $1B in biobucks on Haya to scour dark genome for obesity targets

Fierce Biotech

Wed, 09/4/24 - 11:37 am

Haya Therapeutics

New research could ease concerns over suicide risk of obesity drugs

BioPharma Dive

Tue, 09/3/24 - 05:58 pm

Novo builds heart failure case for semaglutide

BioPharma Dive

Fri, 08/30/24 - 11:31 am

cardiovascular disease

Ambrosia lands $16m to ‘improve on existing GLP-1 drugs’

Longevity Technology

Wed, 08/21/24 - 11:26 am

Ambrosia Biosciences

Array Biopharma

Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived

Motley Fool

Sun, 08/18/24 - 09:19 pm

After clearing out heart disease drug, Arrowhead maps out obesity development plans

Fierce Biotech

Wed, 08/14/24 - 10:41 pm

Arrowhead Pharmaceuticals

5 Obesity Readouts to Watch in the Second Half of 2024

BioSpace

Tue, 08/13/24 - 11:47 am

clinical trials

Terns Pharmaceuticals

Novo Nordisk pulls its FDA heart failure submission for Wegovy, will reapply early next year

Fierce Pharma

Wed, 08/7/24 - 11:47 am

Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market

Motley Fool

Sun, 08/4/24 - 06:30 pm

Pfizer’s Bourla confident in company’s obesity drug position, despite delays

Pharma Voice

Thu, 08/1/24 - 11:14 am

GLP-1 drugs are driving up healthcare costs

Medical Marketing and Media

Fri, 07/26/24 - 11:03 am

healthcare costs

Roche says it’ll move quickly with ‘differentiated’ obesity drugs

BioPharma Dive

Thu, 07/25/24 - 10:05 pm

Carmot Therapeutics

Viking shares jump on plans to speed obesity drug into late-stage testing

BioPharma Dive

Thu, 07/25/24 - 11:23 am

Viking Therapeutics

clinical trials

Novo Nordisk's Wegovy gets UK approval for lowering heart risks

Reuters

Tue, 07/23/24 - 11:24 am

Innovent’s Lilly-Partnered Type 2 Diabetes Drug Aces Phase III in China, Inches Closer to Approval

BioSpace

Mon, 07/22/24 - 06:50 pm

Innovent Biologics

NC Medicaid to cover weight-loss drugs like Wegovy, after access cut for state workers

Yahoo/Raleigh News & Observer

Mon, 07/22/24 - 06:48 pm

5 startups looking to compete in the obesity space

BioSpace

Mon, 07/22/24 - 12:03 pm

ProFound Therapeutics

EraCal Therapeutics

Could Pfizer Become a Top Weight Loss Drug Stock? Don't Count on It.

Motley Fool

Sun, 07/21/24 - 11:02 pm

‘Not prudent’ for Novartis to join GLP-1 obesity race as late-runner, says CEO

Fierce Biotech

Thu, 07/18/24 - 11:13 pm

Roche reports positive data from Phase I obesity treatment trial

Clinical Trials Arena

Wed, 07/17/24 - 12:18 pm

clinical trials

Pages